Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer | NEJM

Mariano Provencio, M.D., Ph.D.,; Ernest Nadal, M.D., Ph.D., … with non–small-cell lung cancer (NSCLC) receive a diagnosis of stage III disease.